# MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

> **NCT06555952** · NA · RECRUITING · sponsor: **Clinical Nutrition Research Center, Illinois Institute of Technology** · enrollment: 80 (estimated)

## Conditions studied

- Hypertension
- Pre Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** MegaNatural-BP SR 150Mg Tablet
- **OTHER:** Placebo Capsule

## Key facts

- **NCT ID:** NCT06555952
- **Lead sponsor:** Clinical Nutrition Research Center, Illinois Institute of Technology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-08
- **Primary completion:** 2026-07-22
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06555952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06555952, "MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06555952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*